Forward Management LLC Increases Position in Catalent Inc (CTLT)
Forward Management LLC boosted its position in shares of Catalent Inc (NASDAQ:CTLT) by 10.1% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 6,436 shares of the company’s stock after buying an additional 592 shares during the period. Forward Management LLC’s holdings in Catalent were worth $226,000 as of its most recent SEC filing.
A number of other large investors have also recently made changes to their positions in CTLT. Municipal Employees Retirement System of Michigan boosted its stake in shares of Catalent by 1.6% in the first quarter. Municipal Employees Retirement System of Michigan now owns 57,810 shares of the company’s stock worth $1,637,000 after buying an additional 910 shares during the period. American International Group Inc. boosted its stake in shares of Catalent by 4.1% in the first quarter. American International Group Inc. now owns 306,375 shares of the company’s stock worth $8,677,000 after buying an additional 12,021 shares during the period. Eagle Asset Management Inc. boosted its stake in shares of Catalent by 4.3% in the first quarter. Eagle Asset Management Inc. now owns 291,451 shares of the company’s stock worth $8,253,000 after buying an additional 12,063 shares during the period. Parametrica Management Ltd purchased a new stake in shares of Catalent during the first quarter worth approximately $308,000. Finally, Capstone Asset Management Co. boosted its stake in shares of Catalent by 3.4% in the first quarter. Capstone Asset Management Co. now owns 9,900 shares of the company’s stock worth $280,000 after buying an additional 330 shares during the period.
Catalent Inc (NASDAQ:CTLT) opened at 34.15 on Friday. Catalent Inc has a 12-month low of $21.83 and a 12-month high of $38.73. The stock has a 50 day moving average price of $35.35 and a 200-day moving average price of $31.83. The company has a market cap of $4.27 billion and a price-to-earnings ratio of 40.22.
TRADEMARK VIOLATION WARNING: This story was reported by Daily Political and is owned by of Daily Political. If you are viewing this story on another website, it was illegally stolen and republished in violation of United States & international trademark and copyright law. The legal version of this story can be accessed at https://www.dailypolitical.com/2017/08/12/forward-management-llc-increases-position-in-catalent-inc-ctlt.html.
A number of equities research analysts have commented on CTLT shares. Zacks Investment Research raised Catalent from a “hold” rating to a “buy” rating and set a $31.00 price objective for the company in a research note on Thursday, April 20th. TheStreet raised Catalent from a “c” rating to a “b-” rating in a research note on Wednesday, April 19th. BidaskClub cut Catalent from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, June 27th. Bank of America Corporation reissued a “buy” rating and issued a $38.00 price objective (up previously from $37.00) on shares of Catalent in a research note on Friday, July 21st. Finally, William Blair raised Catalent from a “market perform” rating to an “outperform” rating in a research note on Monday, May 15th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $32.00.
In other Catalent news, SVP Christine Dolan sold 745 shares of the stock in a transaction on Tuesday, August 1st. The stock was sold at an average price of $34.85, for a total transaction of $25,963.25. The sale was disclosed in a filing with the SEC, which is available through this link.
Catalent, Inc provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. Its segments include Softgel Technologies, Drug Delivery Solutions and Clinical Supply Services. The Softgel Technologies segment is engaged in the formulation, development and manufacturing of prescription and consumer health soft capsules or softgels.
Want to see what other hedge funds are holding CTLT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Catalent Inc (NASDAQ:CTLT).
Receive News & Ratings for Catalent Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catalent Inc and related companies with MarketBeat.com's FREE daily email newsletter.